Todd P. Kelsey - Feb 3, 2025 Form 4 Insider Report for PLEXUS CORP (PLXS)

Role
President & CEO, Director
Signature
/s/ Todd P. Kelsey, by Kate A. Gitter, Attorney-in-Fact
Stock symbol
PLXS
Transactions as of
Feb 3, 2025
Transactions value $
-$1,102,305
Form type
4
Date filed
2/5/2025, 05:07 PM
Previous filing
Jan 31, 2025
Next filing
Feb 13, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLXS Common Stock, $.01 par value Sale -$205K -1.5K -1.7% $136.96 86.9K Feb 3, 2025 Direct F1
transaction PLXS Common Stock, $.01 par value Sale -$280K -2K -2.3% $140.00 84.9K Feb 4, 2025 Direct
transaction PLXS Common Stock, $.01 par value Sale -$283K -2K -2.35% $141.50 82.9K Feb 5, 2025 Direct
transaction PLXS Common Stock, $.01 par value Sale -$334K -2.34K -2.82% $142.86 80.6K Feb 5, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLXS Restricted Stock Units Award +28K 28K Feb 3, 2025 Common Stock, $.01 par value 28K Direct F3
transaction PLXS Performance Stock Units Award +28K 28K Feb 3, 2025 Common Stock, $.01 par value 28K Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares were sold pursuant to a Rule 10b5-1 plan adopted on August 16, 2024.
F2 This transaction was executed in multiple trades at prices ranging from $$142.60 to $$143.15 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 3, 2028.
F4 Each Performance Stock Unit ("PSU") granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock if certain conditions are satisfied. Vesting of 14,030 PSUs is dependent on the relative total shareholder return ("TSR") of Plexus Corp.'s common stock as compared to companies in the S&P 400 Index and vesting of the remainder is based on goals related to economic return ("ER") during the three-year performance period. The target number of PSUs that may be earned is reported above. The reporting person may earn up to 150% of the targeted amount that is based on TSR and up to 200% of the targeted amount that is based on ER.